Skip to content
drillr.ai

HIMS

Hims & Hers Health, Inc.

NYSE · USHealthcareMedical - Equipment & Services
$32.70-0.43%

Price as of Jul 20, 2026

HIMS news

Hims & Hers Health, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

    Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CF

    Business Wire ·

  2. Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data

    NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C., a nationally recognized plaintiffs’ litigation firm with a longstanding focus on consumer data privacy, announces its ongoing investigation of claims on behalf of all United States residents into Hims & Hers Health, Inc. for its alleged ongoing improper data sharing and tracking of users’ private health information. Allegations Involving Hims & Hers Hims & Hers Health, Inc. has allegedly collected and shared subscribers’ and s

    Globe Newswire ·

  3. Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

    Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026 Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960

    Business Wire ·

  4. Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / June 16, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgand

    ACCESSWIRE ·

  5. Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

    Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world's largest consumer health platform. In Germany, the closing strengthens

    Business Wire ·

  6. Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

    Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians Building on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record — to more Canadians than ever Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of

    Business Wire ·

  7. Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

    Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform The acquisition extends the company's leadership position across Australia, Canada, Germany, Japan, and the United Kingdom, with the scale to redefine healthcare for hundreds of millions of people Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier ac

    Business Wire ·

  8. Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

    Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure be

    Business Wire ·

  9. Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

    Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world's largest consumer health platform an

    Business Wire ·

  10. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Shareholders to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgandg

    ACCESSWIRE ·

  11. Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

    Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational infrastructure to drive anticipated cost efficiencies, and enhances the consumer experience with AI and its closed-l

    Business Wire ·

  12. Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

    Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational infrastructure to drive anticipated cost efficiencies, and enhances the consumer experience with AI and its closed-loop data

    Business Wire ·

  13. Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 17, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgandg

    ACCESSWIRE ·

  14. Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

    Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors If elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, tech, and consumer expertise Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company’s 2026 annual shareholder meeting in June. This press release features multimedia. View the full r

    Business Wire ·

  15. Bronstein, Gewirtz & Grossman, LLC Encourages Hims & Hers Health, Inc. (HIMS) Investors to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 23, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgan

    ACCESSWIRE ·

  16. Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Stockholders to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgan

    ACCESSWIRE ·

  17. Bronstein, Gewirtz & Grossman, LLC Encourages Hims & Hers Health, Inc. (HIMS) Shareholders to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 9, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgand

    ACCESSWIRE ·

  18. HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

    LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm (https://www.globenewswire.com/Tracker?data=-hGx-qYGc_qdOymufbL8KHWNranzBmrE-dB4y6bB8-64IPu1iuFZQ7uRI0pRRTubblpDLbLx5n56ePXmQT3XPsYmQ_hL1ROKA0sYK8s_Lkw=), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS (https://www.globenewswire.com/Tracker?data=S2WX1WtBW6A2cWaeu4ZdHRoWfleC1SFoE4Vgo9pdhmyVG8Jd

    Globe Newswire ·

  19. Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

    Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ksfcounsel.com%2F&esheet=54479007&newsitemid=20260403774577&lan=en-US&anchor=Kahn+Swick+%26amp%3B+Foti&index=1&md5=456eee792e9a4b0c131c62dd5dc216b0) , LLC (“KSF”), announces t

    Business Wire ·

  20. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Investors to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 31, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HIMS. (https://bgan

    ACCESSWIRE ·